Correlation Between Arrowhead Pharmaceuticals and Boundless Bio,

Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Boundless Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Boundless Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Boundless Bio, Common, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Boundless Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Boundless Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Boundless Bio,.

Diversification Opportunities for Arrowhead Pharmaceuticals and Boundless Bio,

0.01

Correlation Coefficient

Arrowhead Pharmaceuticals  Boundless Bio,

Significant diversification

The 3 months correlation between Arrowhead and Boundless is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Boundless Bio, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Boundless Bio, Common and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Boundless Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Boundless Bio, Common has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Boundless Bio, go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and Boundless Bio,

Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to under-perform the Boundless Bio,. But the stock apears to be less risky and, when comparing its historical volatility, Arrowhead Pharmaceuticals is 1.66 times less risky than Boundless Bio,. The stock trades about -0.32 of its potential returns per unit of risk. The Boundless Bio, Common is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  269.00  in Boundless Bio, Common on October 4, 2024 and sell it today you would earn a total of  21.00  from holding Boundless Bio, Common or generate 7.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arrowhead Pharmaceuticals  vs.  Boundless Bio, Common

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Boundless Bio, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound essential indicators, Boundless Bio, is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Arrowhead Pharmaceuticals and Boundless Bio,

The main advantage of trading using opposite Arrowhead Pharmaceuticals and Boundless Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Boundless Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Boundless Bio, will offset losses from the drop in Boundless Bio,'s long position.

The idea behind Arrowhead Pharmaceuticals and Boundless Bio, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.